Atovaquone/Proguanil (Malarone) for malaria.
D015746:Abdominal Pain / Q000139:chemically induced; D000284:Administration, Oral; D000962:Antimalarials / Q000627:therapeutic use*; D053626:Atovaquone; D002986:Clinical Trials as Topic; D004338:Drug Combinations; D004347:Drug Interactions; D005252:Fees, Pharmaceutical; D006801:Humans; D016778:Malaria, Falciparum / Q000188:drug therapy* / Q000517:prevention & control*; D009285:Naphthoquinones / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics; D009325:Nausea / Q000139:chemically induced; D002727:Proguanil / Q000008:administration & dosage* / Q000009:adverse effects / Q000191:economics / Q000493:pharmacokinetics
D000962:Antimalarials; D004338:Drug Combinations; D009285:Naphthoquinones; C109496:atovaquone, proguanil drug combination; D002727:Proguanil; D053626:Atovaquone